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In the advanced stages of mycobacterial infections, host immune systems tend to change from a Th1-type to Th2-type immune
response, resulting in the abrogation of Th1 cell- and macrophage-mediated antimicrobial host protective immunity. Notably, this
type of immune conversion is occasionally associated with the generation of certain types of suppressor macrophage populations.
During the course of Mycobacterium tuberculosis (MTB) and Mycobacterium avium-intracellulare complex (MAC) infections, the
generationofmacrophageswhichpossessstrongsuppressoractivityagainsthostT-andB-cellfunctionsisfrequentlyencountered.
This paper describes the immunological properties of M1- and M2-type macrophages generated in tumor-bearing animals and
those generated in hosts with certain microbial infections. In addition, this paper highlights the immunological and molecular
biological characteristics of suppressor macrophages generated in hosts with mycobacterial infections, especially MAC infection.
1.Introduction
Worldwide, tuberculosis (TB) is a major global health con-
cern because it is a highly contagious and life-threatening
infection [1–3]. Moreover, the enhanced susceptibility to TB
in human immunodeﬁciency virus- (HIV-) infected pop-
ulations is another serious health problem [4]. Notably,
multidrug-resistant- (MDR-) TB including extensively drug-
resistant- (XDR-) TB, is currently increasing in the world [5,
6]. On the other hand, Mycobacterium avium-intracellulare
complex (MAC) infections are frequently encountered in
immunocompromised hosts, especially AIDS patients [7,
8], although nodular-bronchiectasis type MAC infections
without predisposing conditions are steadily increasing,
particularly in Japan [9, 10].
In general, during the early to middle stages of mycobac-
terial infections, Th1 cell-mediated immune responses are
dominant and play crucial roles in the establishment and
expression of antimycobacterial host resistance (Figure 1)
[11, 12]. However, in the advanced stages of mycobacterial
infections such as TB and M. avium infection, host immune
systems tend to adopt a Th2-type immune response through
the induction and activation of Th2 cells, thereby resulting
in a diminishment of Th1 cell- and activated macrophage-
mediated antimycobacterial cellular immunity (Figure 1)
[13–17]. Notably, this type of immune deviation is occa-
sionally associated with the generation of certain types of
immunosuppressive macrophage populations. Indeed, dur-
ing the course of infections with Mycobacterium tuberculosis
(MTB) and MAC in humans and experimental animals, the
generation of macrophage populations that possess strong
suppressor activity against host T-cell function is generally
observed. It appears that immunosuppressive macrophages,
particularly those exerting suppressor activity against T
cells, play important roles in mycobacterial persistency in
hosts and the establishment of immune unresponsiveness
in advanced stages of infection. Therefore, it is important2 Clinical and Developmental Immunology
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Figure 1: Cytokine networks in hosts with mycobacterial infection. In this cytokine network, proinﬂammatory cytokines, including IL-
12, IL-23, IL-18, and tumor necrosis factor-α (TNF-α), which are produced by infected macrophages (MΦs) and dendritic cells (DCs),
induce the cellular expansion and diﬀerentiation of Th1 cells, resulting in enhanced production of Th1 and Th1-like cytokines, such as
interferon-γ (IFN-γ), IL-2, TNF-α, and granulocyte-macrophage colony-stimulating factor (GM-CSF). These cytokines play crucial roles in
the expression of host resistance against mycobacterial infections. In addition, immunosuppressive cytokines and humoral factors, such as
IL-4, IL-10, transforming growth factor-β (TGF-β), and prostaglandin E (PGE), which are produced by Th2 cells, Treg cells, Th3 cells, and
macrophages, appear to play important roles in the establishment of immunodeﬁciency frequently encountered in persistent and advanced
infection with mycobacterial pathogens, including MTB.Clinical and Developmental Immunology 3
to elucidate the precise nature of such immunosuppressive
macrophage populations.
In this context, we should note the phenomenon of
macrophage polarization in bacterial infections, particularly
those due to facultative intracellular pathogens, such as
mycobacteria, Salmonella species, and Listeria monocytogenes
[17, 18]. Recent studies on the gene expression proﬁling
of macrophages have revealed that various bacteria induce
the transcriptional activity of a common host response,
which includes genes belonging to the M1 program, asso-
ciated with macrophage polarization yielding classically
activated macrophages (called M1 macrophages) exerting
proinﬂammatory and/or microbicidal functions. However,
excessive or prolonged M1 polarization of macrophages
leads to tissue injury and contributes to pathogenesis [19].
The so-called alternatively activated macrophages (called
M2 macrophages) having immunosuppressive and tissue-
repairing functions play critical roles in the resolution
of harmful inﬂammation by producing anti-inﬂammatory
mediators [17–19].
In this paper article, with the M1 and M2 polarization
of macrophages in mind, we will describe the immuno-
logical properties of (1) alveolar macrophages which have
spontaneous immunosuppressive activity and (2) suppressor
macrophages produced in hosts with protozoal infections,
and (3) the immunological and molecular biological char-
acteristics of immunosuppressive/suppressor macrophages
generated in hosts with mycobacterial infections, especially
MAC infection.
2. Macrophage Polarization and
Suppressor Macrophages
Immunosuppressive/suppressor macrophages induced by
microbial infections, including mycobacteriosis and proto-
zoiasis described below, have properties in common with
those of M2 alternatively activated macrophages. Thus, this
section will deal with the relationship between in vivo
generation of suppressor macrophages and macrophage
M2 polarization. In response to extracellular signals of
cytokines and microbial stimuli, cells belonging to the
macrophage lineage express specialized and polarized func-
tional properties [18, 20–25]. There are mainly two types
of polarized macrophages, generally called M1 and M2
macrophages (Table 1), although some investigators argue
against such a classiﬁcation, because these cells might be
able to change from one phenotype to another, and there is
no straightforward correspondence of phenotype between T
cell subsets and subpopulations of other immune cells [20].
These investigators prefer to call M1 and M2 macrophages
“classically activated macrophages” and “alternatively acti-
vated macrophages,” respectively. As shown in Table 1,M 1
classically activated macrophages are induced to develop by
interferon-γ (IFN-γ) alone or in combination with other
macrophage-activating cytokines, including tumor necro-
sis factor-α (TNF-α) and granulocyte-macrophage colony-
stimulating factor (GM-CSF), and certain microbial stimuli
such as lipopolysaccharide (LPS). In contrast, Th2-derived
cytokines, IL-4 and IL-13, have been demonstrated to
generateM2alternativelyactivatedmacrophages[20,26,27].
In this context, it is noteworthy that the M2 alternatively
activated macrophages consist of three subpopulations; M2a
macrophages induced with IL-4 and IL-13 (classical activa-
tion);M2bmacrophages(correspondingtoTypeII-activated
macrophages) induced with immune complex and Toll-like
receptor (TLR)/IL-1 receptor (IL-1R) ligands via Fc receptor
1 (FcRl), complement receptors and TLR; M2c macrophages
generated in response to IL-10 and glucocorticoid hormones
[17, 18, 21, 28–30]. Notably, in classical activation of
macrophages causing M1 polarization, NF-κB pathway plays
a central role in the response to proinﬂammatory cytokines,
such as IFN-γ, and microbial-associated molecular patterns
[31]. In addition, transcription factor, interferon regulatory
factor 5 (IRF5), has recently been reported to act as another
important M1 regulatory factor [32]. IRF5 participates in
the activation of genes encoding IL-12, IL-23, and proin-
ﬂammatorycytokinesandrepressesthegeneencodingIL-10,
resulting activation of macrophages into M1 cells, which are
capableof setting up the environment fora potent Th1-Th17
response [32]. Thus, IRF5 functions as a factor, which pro-
motes M1 macrophage polarization. On the other hand, c-
Maf, a basic leucine zipper transcription factor, and galectin-
3, a carbohydrate-binding lectin expressed on macrophage
cell membrane, play crucial roles in M2 polarization, espe-
cially in the case of M2 alternatively activated macrophages
[33, 34]. Moreover, IκB kinase β (IKKβ) inhibits the M1
classicallyactivatedmacrophagephenotypethroughnegative
cross-talk with the signal transducer and activator of tran-
scription (STAT) 1 pathway [31]. In relation to M1 and M2
polarization,humanmonocytesinducedtodiﬀerentiatewith
GM-CSF or macrophage colony-stimulating factor (M-CSF)
are also known to have M1 and M2 properties, respectively,
and have been called Mφ1a n dM φ2[ 35].
In general, as reported by Martinez et al. [36], M1 and
M2 macrophage populations have distinct phenotypes due
to diﬀerential proﬁles of gene expression with each other,
as follows (Table 1). First, typical M1 classically activated
macrophages have a phenotype with a high level production
of IL-12 and IL-23 but a low level expression of IL-10. They
are eﬃcient producers of cytotoxic eﬀector molecules, such
asreactiveoxygenintermediates(ROIs)andreactivenitrogen
intermediates (RNIs) and inﬂammatory cytokines, including
IL-1β,T N F - α, and IL-6. Thus, M1 macrophages participate
as inducer and eﬀector cells in polarized Th1 responses and
mediate resistance against intracellular parasites and tumors
[20–22]. In contrast, the various forms of M2 macrophages
share a phenotype with a low level production of IL-12
and IL-23 but a high level expression of IL-10. In general,
M2 alternatively activated macrophages are characterized by
low production of proinﬂammatory cytokines including IL-
1, TNF-α, and IL-6. However, M2b macrophages (type II-
activated/regulatory macrophages), which are characterized
by high levels of IL-10 and CD86 expression, but low levels
of IL-12 and arginase 1 expression, are good producer of IL-
1, TNF-α, and IL-6, as in the case of M1 classically activated
macrophages [28–30]. In addition, M2b type II-activated
macrophages retain high level expression of inducible nitric
oxide synthase (iNOS) and RNI production [28–30].4 Clinical and Developmental Immunology
Table 1: Functional proﬁles of M1, M2, and suppressor macrophagesa.
Expression of
Degree of expression or production
M1 MΦsb M2 MΦs Suppressor MΦsc
IL-12 ++ −
IL-23 ++ −
IL-10 − ++ +
TNF-α ++ − (M2b+)d +
IL-1 ++ − (M2b+)d
IL-1ra + ++ (M2a, M2c)e
IL-6 ++ − (M2b+)d ++
Type I IFN ++ −
TGF-β − +( M 2 c ) −
CCL1 − ++ (M2b)
CCL2, 5, 15, 19 +++ + (M2a)
CXCL9, 10, 11,16 +++ +
CCL13, 17, 18, 22, 23, 24 + ++ (M2a)
IL-1R1 ++ +
IL-2Rα ++ + (M2a)
IL-15Rα ++ + (M2a)
Scavenger receptor − +( M 2 c )
Mannose receptor + +++ (M2a, M2c)
TLR2, TLR4 ++ +
TLR5 + ++ (M2a)
CD14 + ++ (M2c)
FcRb ++ +
CCR2 + ++ (M2c)
CCR7 +++ −
CXCR4 + ++ (M2a)
MHC-II + − (M2b+)d
CD86 (B7.2) + − (M2b+)d
Fizz1b − ++ (M2a)
Ym1b − ++ (M2a)
Galectin-3 + ++ (M2a, M2c)
iNOS ++ − (M2b++)d +
Arginase 1 − ++ (M2a, M2c)
IPDb +++ +
COX-1b ++ + ( M 2 a )
COX-2b ++ − (M2a)
RNI ++ − (M2b+)d ++
ROI ++ − (M2b+)d ++
Polyamine − ++ (M2a, M2c)
aPrevious ﬁndings described in the following papers are summarized: in References [18, 20, 21, 27, 29, 36–38].
bAbbreviations: MΦs, macrophages; FcR, Fc receptor; Fizz1, found in inﬂammatory zone 1; Ym1, M2-associated chitinase-like protein; IPD, indoleamine-
pyrrole 2,3 dioxygenase; COX, cyclooxygenase.
cFindings on suppressor macrophages induced by mycobacteriosis and protozoiasis are indicated. In cases of these macrophages, proﬁles of cytokine,
chemokine, receptor, and enzyme expression other than those indicated in this table have not yet been studied, as far as we know.
dExceptionally positive in the case of M2b macrophages.
e Positive or negative, especially in the cases of indicated macrophage populations.Clinical and Developmental Immunology 5
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scavenger, mannose, and galactose-type receptors. Moreover,
in M2 macrophages, arginine metabolism is shifted to
production of ornithine and polyamines via arginase 1 (Arg
1) [20, 21, 39]. Moreover, M1 classically activated ma-
crophages and the various forms of M2 alternatively acti-
vated macrophages have distinct chemokine and chemokine
receptor repertoires [21]. M2 macrophages principally play
important roles in polarized Th2 reactions. For instance,
(1) M2 macrophages promote the killing and encapsulation
of para-sites; (2) M2 macrophages present in established
tumorsandpromoteprogression,tissuerepair,andremodel-
ing; (3) M2 macrophages have immunoregulatory and anti-
inﬂammatory functions [20, 22]. In addition, it has been
indicated that M2 macrophages inhibited the generation of
M1 macrophages and that CCL17 and IL-10 mediated the
actions of M2 macrophages as humoral eﬀectors [22].
As clearly described by Muray and Wynn [19], after
infection or tissue injury, the ﬁrst responder macrophages
usually exhibit an inﬂammatory phenotype and secrete
proinﬂammatory mediators, such as TNF-α,I L - 1 ,R N I s ,a n d
ROIs, thereby causing activation of antimicrobial mecha-
nisms characteristic of M1 classically activated macrophages.
These macrophages also generate IL-12 and IL-23, which
are decisive in cell expansion and the diﬀerentiation of
Th1 and Th17 cells [40, 41]. Thus, the M1 program of
macrophages is usually associated with protection during
acute infectious diseases. However, RNIs and ROIs produced
by such activated macrophage populations are toxic and
highly damaging to neighbouring tissues. Therefore, antimi-
crobial/inﬂammatory M1 classically activated macrophages
must be controlled to prevent collateral extensive tissue
damage by regulatory mechanisms, including the generation
of M2 alternatively activated macrophages, which antagonize
M1 polarization of macrophages and also exert strong anti-
inﬂammatoryactivity.Inaddition,M2alternativelyactivated
macrophages play important roles in wound healing and
ﬁbrosisbygeneratinggrowthfactors,includingtransforming
growth factor-β (TGF-β) and platelet-derived growth factor,
whichactonﬁbroblasts,epithelialcells,andendothelialcells,
causing enhanced cellular growth, angioneogenesis, and the
production of extracellular matrix [19, 42, 43].Should we
change the highlighted “angioneogenesis” to “angiogene-
sis” As commented by Lugo-Villarino et al. [17], macro-
phages undergo diﬀerent programs of activation, rendering
them either proinﬂammatory and microbicidal (M1 macro-
phages) or immunosuppressants and tissue repairers (M2
macrophages). An excess of prolonged polarization of either
program may be detrimental to the host due to potential
tissue injury or contribution to pathogenesis. Indeed, the
predominant type 2 inﬂammatory environment shifts back
to type 1 after successful treatment of pulmonary TB in
infected patients [15, 17].
In this context, it has been demonstrated that the com-
monresponseofmacrophagestobacterialinfectionsinduced
by MTB, Mycobacterium bovis BCG, Bordetella pertussis,
Chlamydophila pneumoniae, Legionella pneumophila,a n d
so forth, involves upregulation of genes involved in M1
polarization of macrophages. These induced genes encoding
cytokines such as TNF, IL-6, IL-12, IL-1β, cytokine receptors
such as IL-7R, IL-15 receptor α (IL-15RA), chemokines such
as CCL2, CCL5, and CXCL8, and the chemokine receptor
CCR7. On the other hand, IL-1 receptor antagonist (IL-1ra)
appears to be the only gene associated with M2 polarization
ofmacrophagesthatisexpressedafterbacterialchallenge[18,
44]. Some bacterial pathogens have evolved sophisticated
strategiestopreventM1polarization,neutralizemicrobicidal
eﬀectors of macrophages, or promote M2 polarization [18].
With respect to mycobacterial diseases, the following proﬁles
are known. First, during the early phase of MTB infection,
M1 polarization of host macrophages is evident and this is
in agreement with the clinical proﬁles of patients with active
TB. However, a small population of TB patients is known to
exhibit M2 polarization, which can be reversed by eﬀective
chemotherapy, indicating the role of M2 polarization in
the chronic evolution of TB [18, 45]. In this context, a
recent study by Redente et al. demonstrated the following
[46]. In their experimental infection model in mice, MTB
resulted in pulmonary inﬂammation characterized by an
inﬂux of macrophages, followed by systemic eﬀects on the
bone marrow and other organs. In this infection model,
pulmonary IFN-γ and IL-4 production coincided with the
altered polarization of alveolar macrophages. Soon after
MTB infection, IFN-γ content in bronchoalveolar lavage
ﬂuid (BALF) increased, and bronchoalveolar lavage (BAL)
macrophages became M1 classically activated macrophages,
as characterized by increased expression of iNOS and pro-
duction of RNIs. As inﬂammation progressed in the model,
the amount of IFN-γ in BALF and iNOS expression by
BAL macrophages decreased and, thereafter, the IL-4 content
in BALF and arginase 1 expression by macrophages rose,
indicatingM2polarizationofBALmacrophages.Indeed,at7
days after infection, BAL macrophages were Arg1lowiNOSlow.
By day 21, BAL macrophages were Arg1lowiNOShigh (M1-
type) and those isolated 35 to 60 days after MTB exposure
were Arg1highiNOSlow (M2-type), thereby indicating a switch
from M1 to M2 polarization of macrophages. Notably, in
this infection model, macrophages present in MTB-induced
granulomas remained M1-polarized [46]. In connection
with this ﬁnding, Ito et al. [47] revealed that the lungs
of TLR9-deﬁcient mice, which were injected intravenously
with puriﬁed protein derivative (a mixture of MTB anti-
gens) 2 weeks after sensitization with complete Freund’s
adjuvant containing heat-killed MTB, developed a type
2-like response with signiﬁcantly larger granulomas and
increased accumulation of eosinophils compared to control
mouse granulomas. This phenomenon was associated with
a selectively abrogated type-1 and enhanced type 2 cytokine
proﬁle in the lungs. In this case, macrophages in the lungs
of TLR9-deﬁcient mice expressed signiﬁcantly lower levels of
the M1 macrophage marker, iNOS, but higher levels of M2
macrophage markers such as arginase 1 and Fizz 1 (found
in inﬂammatory zone 1). These ﬁndings showed that lung
macrophages were shifted from M1 to M2 type in TLR9-
deﬁcient mice, thereby suggesting that TLR9 plays an impor-
tant role in maintaining the appropriate phenotype in a Th1
granulomatous response. In relation to this, overexpression
of IL-10 is characteristic of lepromatous leprosy in humans6 Clinical and Developmental Immunology
and this phenomenon is attributable to M2 polarization of
hostmacrophages[18,45,48].Thegeneexpressionproﬁleof
lepromatous lesions is enriched for M2 genes, such as CD36,
CD163, scavenger receptor-A, and macrophage receptor
with collagenase structure (MARCO), when compared with
tuberculoid lesions. In contrast, antimicrobial proﬁle based
on M1 program dominates in tuberculoid lesions [45, 49].
With special reference to M2 diﬀerentiation of macro-
phages, the following ﬁnding by Liao et al. [50]i sn o t e w o r -
thy. They found that Kr¨ uppel-like factor 4 (KLF4) functions
as a critical regulator of macrophage polarization, that is,
KLF4 expression was robustly induced in M2 alternatively
activatedmacrophagesandstronglyreducedinM1classically
activated macrophages. Mechanistically, KLF4 was found to
cooperate with STAT6 to induce an M2 genetic program and
inhibit M1 targets via sequestration of coactivators required
for NF-κB activation. KLF4-deﬁcient macrophages demon-
strated increased expression of proinﬂammatory genes
encoding TNF-α, iNOS, cyclooxygenase 2, RANTES, and
macrophage chemoattractant protein-1 (MCP-1), decreased
expression of prototypical target genes that characterize the
M2 phenotype, such as arginase-1 (Arg1), mannose receptor
(Mrc1), resistin-like molecule α (Fizz1), chitinase-like 3
(Chi313), enhanced bactericidal activity against Escherichia
coli, and altered metabolism. These ﬁndings indicate that
KLF4 as well as other transcription factors such as galectin 3,
a good distinctive descriptor of M2a and M2c macrophages,
is a regulator of macrophage M2 polarization [17, 37, 38,
50]. It has also been reported that MTB and its cell wall
mannose-capped lipoarabinomannan (Man-LAM) induced
the expression of peroxisome proliferator-activated receptor
γ (PPAR-γ) in monocyte-derived macrophages through the
mannose receptor-dependent pathway [51]. In this context,
PPAR-γ isanuclearfactorthatischaracteristicofM2alterna-
tive activation of macrophages, because of its strong expres-
sion by M2 macrophages, and is thought to be critical for
intramacrophage survival of infected mycobacteria [45, 48].
Notably, activated PPAR-γ promoted IL-8 and cyclooxyge-
nase 2 expression in a mannose receptor-dependent manner
[51]. Furthermore, MTB- or Man-LAM-induced PPAR-γ-
mediated IL-8 response was independent of NF-κBa c t i -
vation and TLR-2 expression. In contrast, infection with
attenuated Mycobacterium bovis BCG induced less PPAR-
γ e x p r e s s i o na n de l i c i t e dI L - 8p r o d u c t i o ni na nN F - κB-
independent manner. These ﬁndings suggest that PPAR-γ
functions as one important “molecular switch” in regulating
macrophage immune responses to MTB, particularly in M2
polarization.
On the other hand, recent ﬁnding by Franc ¸ois et al.
[52] is also interesting. They demonstrated that human
bone-marrow-derived mesenchymal stromal cells (MSCs)
derived from normal adult donors possess immunosup-
pressive potential. Using MSCs from diﬀerent donors, they
showed variability between donors in their ability to sup-
press T-cell proliferation induced by anti-CD3 and anti-
CD28 antibodies. Notably, in this case, enzymatic activity
indoleamine 2,3-dioxygenase (IDO), an IFN-γ-inducible
intracellular enzyme, of MSCs was the main mechanisms
of T cell suppression. Moreover, the enzymatic activity of
IDO was partially implicated in the diﬀerentiation of blood
monocytes into IL-10-secreting M2-type immunosuppres-
sive macrophages. Those monocyte-derived M2 alternatively
activated macrophages are in turn implicated in the suppres-
sion of T cell proliferation in an IL-10-independent manner,
thusamplifyingtheimmunosuppressiveeﬀectbyMSCs.This
ﬁnding is interesting because it indicates a novel mechanism
of IDO-mediated tolerance induction, mainly by inducing
T-cell apoptosis/anergy and the generation of M2-type
suppressor macrophages and regulatory T cells, in addition
to biochemical mechanisms, including tryptophan depletion
and several metabolites of the kynurenine pathway. In
connection with such M2-type suppressor macrophages, the
followingsituationsarenoteworthy.Onepathwaydependent
on the TLR adaptor protein myeloid diﬀerentiation marker
88 (MyD88) induces the expression of arginase 1 during
intracellular infections, whereas another pathway, which
depends on the STAT6, is required for arginase 1 expression
in M2 macrophages. Recently, Qualls et al. [53]r e p o r t e d
that M. bovis BCG-infected macrophages produced soluble
factors, including IL-6, IL-10, and granulocyte colony-
stimulating factor (G-CSF), that induced the expression
of arginase 1 characteristic of M2 alternatively activated
macrophages in an autocrine-paracrine manner. Arginase 1
expression was controlled by the MyD88-dependent produc-
tion of these cytokines rather than by cell-intrinsic MyD88
signaling to arginase 1. They revealed that the MyD88-
dependent pathway that induced the expression of arginase
1 after infection by mycobacteria required STAT3 activation
and that this pathway may cause the development of an
immunosuppressive niche in granulomas because of the
induced production of arginase 1 in surrounding uninfected
macrophages. However, tyrosine phosphorylation of STAT-
6, which is necessary for the expression of arginase 1 in
response to IL-4, IL-13, or both, was not observed in this
experimental system. Therefore, although BCG infection
induces the expression of arginase 1 in macrophages, it
is unlikely that these cells correspond to M2 alternatively
activated macrophages.
It is noteworthy that M2 macrophage subpopulations
share functional properties characteristic of suppressor
macrophages.Indeed,immaturemyeloidsuppressorcellsare
known to have functional properties and a transcriptional
proﬁle related to M2 macrophages [22]. However, it may be
noteworthy that M1 classically activated macrophages have
also been demonstrated to display suppressor activity against
lymphocytes by releasing immunosuppressive mediators
including RNIs, TGF-β and prostaglandin E2 (PGE2). Thus,
it is unclear whether such types can be regarded as “suppres-
sor macrophages” and, indeed, some investigators argued
that nitric oxide-mediated inhibition of the cytotoxic T lym-
phocyte (CTL) response by tumor-associated macrophages
is merely a side eﬀect of the activation of macrophages rather
than a result of the action of a distinct subset of what have
been termed suppressor macrophages [54]. Nevertheless,
such macrophage populations are thought to play critical
roles in the negative regulation of host protective immunity
against tumors and microbial infections.Clinical and Developmental Immunology 7
3. ImmunosuppressiveFunctionsof
AlveolarMacrophages
In the tissues of the lungs and respiratory tract, where host
immune cells have abundant opportunities to encounter and
interact with inhaled antigens/immunogens and irritating
substances/particulates of external origin, cellular functions
of local T lymphocytes tend to be excessively upregulated in
response to constitutive and potent antigenic signals. There-
fore, negative immunoregulatory systems exist to maintain
homeostasis in the lungs. Alveolar macrophages, as resident
cells of the lungs, play critical roles in such systems. They
have a distinct phenotype compared with other types
of resident macrophages in the body. For instance, alve-
olar macrophages constitutively secrete proinﬂammatory
cytokines, presumably as a result of stimulation by external
particulates via their pattern-recognition receptors, includ-
ing mannose receptors, scavenger receptors, and β-glucan
receptors [55]. Thus, alveolar macrophages are central to
innate defense systems of the airway. Moreover, they are
also known to secrete immunosuppressive factors and act
as immunoregulatory cells in the lungs. In fact, resident
alveolar macrophages exhibit suppressive activity against
the mitogen-induced proliferative response of T cells and
antigen-presenting activity of dendritic cells. It thus appears
that alveolar macrophages participate in the immunoregu-
lation of T cell- and B cell-dependent immune responses
in pulmonary tissues and milieus. Spiteri and Poulter [56]
indicated that there are two subpopulations of human alveo-
lar macrophages. One subset is immature-type macrophages
with weak adherence to plastic plates, poor phagocytic
capacity, and poor expression of the Fc receptor (FcR) and
C3b receptor (CR3), but with strong functional activity
as antigen-presenting cells and T-cell stimulator cells in
allogeneic mixed lymphocyte reactions (MLRs). The other
subset is mature-type macrophages with strong adherence,
marked phagocytic ability and strong expression of FcR and
CR3, butwithpoor activity in stimulating MLR.Notably, the
latter FcRhigh and CR3high alveolar macrophage population
acts as suppressor cells by repressing the MLR-stimulatory
activity of the former FcRlow and CR3low population.
Furthermore, according to Upham et al. [57], human
alveolar macrophages induced a reversible suppression of T-
cellresponsetohousedustantigensandphytohemagglutinin
(PHA) without aﬀecting proﬁles of CD3, CD2, CD28, and
IL-2 receptor (IL-2R) expression and without reducing IL-
2p r o d u c t i o nb yt a r g e tTc e l l s ,w h e r e a ss u c hm a c r o p h a g e s
partly inhibited the secretion of IFN-γ by T cells. In this
case, alveolar macrophages were found to markedly suppress
the tyrosine phosphorylation of certain proteins involved
in IL-2R-associated signaling pathways of T lymphocytes.
Notably,theexpressionofsuchinhibitoryactivitybyalveolar
macrophages is achieved via heterogeneous mechanisms,
involving both cell-to-cell contact with the target T cells
and macrophage-derived humoral mediators including RNI
and TNF-α. A similar ﬁnding was also reported for alveolar
macrophages of guinea pigs, except that neither RNI nor
PGE2 plays a critical role as a mediator of their suppressor
action [58]. In any case, these ﬁndings may indicate that the
immunoregulatory properties of alveolar macrophages are
relatively selective, allowing T-cell activation and cytokine
secretion while inhibiting T-cell proliferation within the
lungs. Previously, Rich et al. indicated that the inhibitory
activity of mouse alveolar macrophages against PHA-
inducedT-cellproliferationrequiredcell-to-cellcontactwith
target T cells and that the membranous phosphatidylglycerol
of alveolar macrophages played important roles in their
suppressor activity [59]. On the other hand, in the case of rat
alveolar macrophages, cell-to-cell contact with target T lym-
phocytes is required for production of RNIs as a suppressor
mediator,whichinhibitsconcanavalinA(ConA)-inducedT-
cell mitogenesis [60]. It has also been reported that murine
alveolar macrophages exhibited suppressor activity against
IgM, IgG, IgA, and IgE antibody production by splenocytes
[61].Inthiscase,itisunlikelythatRNIsandROIsparticipate
in the suppressor function of the alveolar macrophages.
Alveolar macrophages are composed of heterogeneous
subpopulations of mononuclear phagocyte lineages with dif-
ferent phenotypes and functional properties. In this context,
it has been demonstrated that resident alveolar macrophages
could be activated by treatment with lymphokines of Con A-
stimulatedTcelloriginintermsofelevatedproductionofIL-
1, IL-6, IL-12, TNF-α,a n dd e f e c t si nT G F - β expression [62].
In contrast, the treatment of resident alveolar macrophages
with1-methyladenosine,animmunosuppressivemoleculein
tumor ascites ﬂuids, caused the generation of a macrophage
subpopulation possessing functional properties character-
istic of suppressor macrophages, as follows: marked TGF-
β-producing ability, low IL-6 expression, and defects in
IL-1, IL-12, and TNF-α production [62]. Taken together,
it can be concluded that some populations of alveolar
macrophages participate in the immunological homeostasis
ofthelungsasnegativeimmunoregulatorysuppressors.With
respecttothegenerationofimmunosuppressivemacrophage
population in the lungs, the following ﬁndings by Arikawa
et al. [63] concerning galectin-9, a β-galactoside binding
lectin functioning as a ligand for T cell immunoglobulin-
and mucin domain-containing molecule 3 (Tim-3), which
is expressed on Th1 and Th17 cells, may be noteworthy.
They found that galectin-9 was expressed on innate immune
cells, such as dendritic cells, and expanded macrophages in
bronchial lavage ﬂuid to CD11b+Ly-6ChighF4/80+ cells hav-
ing immunosuppressive activity against T-cell proliferation
[63].Thisindicatesthatgalectin-9expandsimmunosuppres-
sive macrophages in the lungs to ameliorate Th1/Th17 cell-
mediated hypersensitive pneumonitis in vivo.
4. Immunosuppressive Macrophages Generated
by ProtozoalandHelminth Infections
Impairments of T-cell functions, such as proliferative re-
sponses to antigens and mitogens, and T cell-mediated im-
mune reactions such as delayed-type hypersensitivity are
frequently encountered during primary infections with
protozoal organisms (Trypanosoma, Toxoplasma, etc.) and
helminths (Fasciola,Schistosoma,et c . )[ 64–68]. It is generally8 Clinical and Developmental Immunology
recognized that the establishment of such immune unre-
sponsiveness is mediated by suppressor macrophage popu-
lations generated 2 to 4 weeks after an infection. Suppressor
macrophages induced by Trypanosoma congolense infection
in mice suppressed the proliferative response of Con A-
stimulated T cells via ROI- and prostaglandin-independent
mechanisms [64]. On the other hand, murine splenic
macrophages produced in response to African trypanosome
(Trypanosoma brucei rhodesiense) infection exerted RNI-
and prostaglandin-dependent suppressor activity against the
proliferative response of Con A- and anti-CD3 antibody-
stimulated T cells [65]. In this case, the generation of
suppressor macrophages was in part dependent on IFN-
γ and TNF-α. In particular, the combined eﬀect of IFN-γ
with certain soluble trypanosome products is crucial for the
induction of suppressor macrophages characterized by
enhanced RNI-producing ability due to an increase in the
expression of iNOS [66]. In vivo, the generation of similar
types of suppressor macrophages has been indicated in the
cases of Toxoplasma gondii infection [67]. In this case, the
cooperation of IL-10 and RNIs was found to be critical for
the immunosuppressive action of suppressor macrophages
against T-cell proliferation responding to mitogens, super
antigens and parasite antigens. On the other hand, the
generation of diﬀerent types of suppressor macrophages has
been reported in cases of ﬁlarial and theilerial infections
[69, 70]. The suppressor macrophages induced in mice due
to infection by ﬁlarial nematode, Brugia malayi,e x e r t e d
their suppressive activity against lymphocyte prolifera-
tion in a fashion independent of RNIs, ROIs, and pros-
taglandins [69]. In Theileria annulata-infected cattles, two
types of suppressor macrophages were induced. While the
ﬁrst-type macrophages expressed suppressor activity via a
prostaglandin-mediated pathway, the second-type macro-
phages acted in a prostaglandin-independent manner [70].
Chronicity, immune suppression, and Th2-type immune
responses are characteristic features of infections with mul-
ticellular parasites [68]. Immune suppression and Th2-type
responses have been attributed to chronic helminthic infec-
tions. In cases of helminth infections, the establishment of
macrophage populations having suppressor activity against
T-cell functions has been reported [71–73]. Loss of T
lymphocyte proliferation concomitant with the emergence
of a host response that is dominated by a Th2-type proﬁle
is well-established features of human ﬁlariasis. MacDonald
et al. [71] reported that Brugia malayi infection in mice
generated suppressor macrophage populations by an IL-
4-dependent mechanism. The suppressor activity of these
macrophages was partly dependent on IL-10. However, since
T-cell suppression was induced by B. malayi even in the case
of IL-10-deﬁcient mice, IL-10 appears not to be essential
for T-cell hyporesponsiveness induced by the ﬁlarial infec-
tion. It has been indicated that a Schistosoma mansonii-
derived pentasaccharide, Lacto-N-fucopentaose (LNFP),
induces suppressor macrophage populations with a Gr1+,
F4/80+/CD11b+ (macrophage markers) phenotype via T
cell-independent mechanisms, because such immunosup-
pressive macrophages could be generated in T-cell deﬁcient
SCIDmice[72].Thistypeofsuppressormacrophageblocked
the anti-CD3- and anti-CD28-induced proliferation of naive
CD4+ T cells through nitric oxide- and IFN-γ-dependent
mechanisms [72]. It has recently been reported that immune
suppression was induced in rats with advanced chronic
fascioliasis in connection with the deviation to a Th2-type
immune response [73]. In this case, mononuclear cell prolif-
eration in the host spleen in response to T and B cell mito-
gens was strongly inhibited in infected rats. Notably, early in
the infection, a Th2-type response predominated. However,
this decreased in advanced chronic infection followed by
the subsequent establishment of persistent immune sup-
pression. It appears that the persistent immunosuppressed
state characteristic of the advanced stages of fascioliasis is
alsomediatedbycertainsuppressormacrophagepopulations
generated responding to Th2-type immune deviation in
infected hosts. In this context, a recent ﬁnding reported by
Potianetal.[74]isinteresting.Theyfoundthatmiceinfected
withtheintestinalhelminthNippostrongylusbrasiliensis(Nb)
exhibited transitory impairment of resistance to coinfection
with MTB. In their experimental model, although Nb
infection induced a Th2 response in host mice, thereby
resulting in the accumulation of M2 alternatively activated
macrophages in the lung, the helminth-induced Th2 envi-
ronment did not impair the onset of the MTB-speciﬁc Th1
immune response. Coinfected mice lacking IL-4Rα exhibited
improved ability to control MTB infection, which was
accompanied by signiﬁcantly reduced accumulation of M2
macrophages,suggestingthedirectcontributionoftheIL-4R
pathway to the heightened MTB susceptibility of coinfected
mice. These ﬁndings indicate that the Th2 response can
enhance the intracellular persistence of MTB, in part by
mediating the alternative activation of M2-type suppressor
macrophages via the IL-4Rα signaling pathway.
5. Suppressor Macrophages Generatedby
Mycobacterial Infections
In hosts with mycobacterial infections, Th1-mediated im-
mune responses are dominant and play crucial roles in
the establishment and expression of antimycobacterial resis-
tance. Figure 1 illustrates a cytokine network in hosts with
mycobacterial infections. This network is composed of
very complicated events mediated by various immuno-
competent cells and a number of cytokines produced by
these cells, including the following [11, 12, 75–79]: (1)
activation/maturation of Th1 cells and NK cells in response
to stimulatory signals due to proinﬂammatory cytokines,
including IL-12, IL-23, IL-18, IL-27, TNF-α,I L - 1 ,I L -
7, and IL-15, which are produced by macrophages and
dendritic cells stimulated with certain bacterial components
ofmycobacterialorganisms;(2)activationofmacrophagesin
response to activating signals by proinﬂammatory cytokines,
such as IFN-γ,T N F - α, and GM-CSF produced by Th1
cells and NK cells. These immunological events mediated
by the above cytokines are important for the establish-
ment of mycobacterial immunity and the expression of
host resistance. In contrast to the Th1/NK cell-mediated
upregulation of macrophage antimycobacterial functions,
the following ﬁndings have been obtained with respect toClinical and Developmental Immunology 9
the roles of Th2 cytokines and other immunosuppressive
cytokines in host resistance to mycobacterial infections [11,
12, 75–79]. First, IL-4 produced by Th2 cells, NKT cells,
CD19+/B220+ B cells and neutrophils and IL-10 released
from Th2 cells and macrophages down-regulate the matura-
tion/activation of Th0 cells to Th1 cells directly or indirectly
by inhibiting the production of IL-12 by macrophages.
Second, Th1 cytokines (IFN-γ, etc.) and Th2 cytokines (IL-
4, IL-10, etc.) mutually downregulate the activation of Th2
cells and Th1 cells, respectively. Third, immunosuppressive
cytokines (IL-10, IL-13, TGF-β,e t c . )p r o d u c e db yT h 2
cells and infected macrophages act on macrophages in an
autocrine or paracrine fashion, and thereby down-regulate
the production of RNIs and ROIs and responsiveness to
macrophage-activating cytokines such as TNF-α and IFN-γ
[12, 76, 80]. In addition, It has recently been reported that
blood levels of IL-9, which is presumably produced by Th2
cells,waselevatedinTBpatientscomparedwithpersonswith
latent MTB infection and that IL-9 reduced IFN-γ mRNA
expression in peripheral blood mononuclear cells because of
inhibition of Th1 cell diﬀerentiation [81]. These events lead
to suppression of the bactericidal/bacteriostatic activity of
host macrophages against mycobacterial pathogens.
Mycobacteria cause severely depressed cellular immunity
in the advanced stages of infection [82]. During the course of
persistent and progressing mycobacteriosis in humans and
experimental animals, the generation of immunosuppressive
macrophages is frequently encountered [83, 84]. In the
peripheral blood mononuclear cells of TB patients showing
low tuberculin responses (anergy), the generation of sup-
pressor macrophages populations, which markedly inhibit
host T-cell proliferative responses to antigenic stimulatory
signals with tuberculin-puriﬁed proteins, have been reported
[83]. In addition, suppressor macrophage populations were
generated among the spleen cells obtained from mice
infected with BCG but not those from mice given heat-killed
BCG [84]. The suppressor macrophages inhibited allogeneic
mixed lymphocyte reaction and Con A-induced mitogenesis
of T cells. In the cytokine network illustrated in Figure 1,
Th2 cells produce IL-4 and IL-10, which are able to induce
M2a-typealternativelyactivatedmacrophages,inresponseto
IL-4/IL-1 signals [21]. In addition, macrophages, which have
been primed with Th1 cytokines (IFN-γ) and other proin-
ﬂammatory cytokines (GM-CSF, TNF-α,e t c . )g e n e r a t e db y
NK cells and macrophages, produce IL-10 during infections
with mycobacterial organisms. Notably, IL-10 is a potent
generator of M2c-type immunoregulatory macrophages [17,
21]. Thus, these M2a and M2c macrophages seem to act
as suppressor cells by producing IL-10 and TGF-β which
downregulate T cell and macrophage functions [80, 85, 86].
On the other hand, certain subpopulations of classically
activated M1 macrophages are endowed with suppressor cell
activity against T lymphocytes, since such macrophages are
capable of secreting RNI molecules and PGE2,b o t ho fw h i c h
are potent suppressors of T-cell proliferative responses to
antigenicandmitogenicsignalsandotherT-cellfunctions,as
described below. Therefore, it is thought that suppressor ma-
crophage populations may be generated in hosts in the late
phase of persistent and progressive mycobacterial infections.
5.1. Generation of Suppressor Macrophages during MAC
Infections. In studies of the present author for more than ten
years,similartypesofsuppressormacrophageswerefoundto
develop in mice infected with MAC, as follows [87, 88]. (1)
Splenic T-cell proliferative responses to the Con A stimula-
tory signal were severely reduced around 2 to 3 weeks after a
bacterialchallengewithalargeinoculumofMACpathogens,
followed by a prolonged reduction in the responsiveness of
T cells to Con A. (2) The generation of suppressor macro-
phage populations (plastic- and Sephadex G-10 column-
adherent, Thy-1,2−cells) in the spleen of host mice was
observed around the same periods after MAC infection and
this was accompanied by the concomitant generation of
splenic macrophage populations, which were characterized
by a strongly increased ROI-producing ability in response
to phorbol myristate acetate (PMA) triggering. (3) The
bacterial elimination from the host spleen was most marked
around weeks 2 to 3, indicating that the anti-MAC antimi-
crobial activity of splenic macrophages was most potently
increased during the same periods after the MAC infec-
tion. These ﬁndings suggest that MAC-induced suppressor
macrophages may simply correspond to a macrophage
population, which acquired cellular functions characteristic
ofimmunologicallyactivatedmacrophages,thatis,classically
activatedM1-type macrophages.Therefore,it is possible that
thesamemechanismsunderlietheactivationandacquisition
of suppressor macrophage functions.
In this context, for various types of peritoneal macro-
phages, including resident macrophages, macrophages in-
duced with either thioglycollate, zymosan A, or a strepto-
coccal cell wall preparation, and macrophages induced by
BCG or MAC infection, there was a statistically signiﬁcant
correlation between their suppressor activity and ability to
p r o d u c eR O I s( r = 0.84, P<0.005) [89]. Therefore, it is
thought that the suppressor activity of a given macrophage
generally correlates with its degree of activation in terms of
ROI-producing ability. However, this relationship was not
so tight. There were two exceptional populations, which
were represented by points that deviate markedly from
the normal bivariate distribution in the scatter diagram.
That is, these macrophages had much greater suppressor
activity than expected from the intensity with which they
generated ROIs. Therefore, in certain types of macrophages
there may be a dissociation between the ROI-producing
ability and suppressor activity. These ﬁndings are consistent
with another ﬁnding that the suppressor activity of test
macrophages was not mediated by ROIs themselves. Similar
ﬁndings on a dissociation between functions characteristic
of an activated state and suppressor activity were reported
by Boraschi et al. [90]; that is, macrophages activated by
IFN-γ in vitro showed reduced suppressor activity against
an antigen-speciﬁc lymphoproliferative response, although
they did acquire marked tumoricidal capacity. On the other
hand, such a reduction in suppressor activity was not noted
when macrophages were activated by a lymphokine-rich
supernatant of BCG-primed and puriﬁed protein deriva-
tive (PPD)-activated splenic T cells containing macrophage
activating factor consisting of IFN-γ and other cytokines
such as GM-CSF and TNF-α. Taken together, suppressor10 Clinical and Developmental Immunology
macrophages induced by mycobacterial infections may be
composed of heterogeneous macrophage subpopulations
consisting of at least the two types of macrophages described
above.
5.2. Mechanisms of MAC Infection-Mediated Generation of
Suppressor Macrophages. In order to assess the role of T
cell-mediated immunity in the generation of suppressor
macrophages during MAC infections, the proﬁle of sup-
pressor macrophages among host spleen cells in MAC-
infected athymic nude mice was compared with that in
MAC-infected euthymic mice. The following ﬁndings were
made [91]. First, splenic macrophages possessing suppressor
activity occurred not only in euthymic mice but also in
athymic mice at around weeks 2 to 3. This implies that
mature T cells are not a prerequisite for the generation of
MAC-induced suppressor macrophage populations and that
suppressor macrophage populations were produced not only
through a T cell-dependent pathway but also through a T
cell-independent mechanism in host animals with severe
MAC infections. However, the suppressive activity was about
four times greater in euthymic mice than in athymic mice,
indicating that mature T cells are required for the gener-
ation of macrophage populations with highly potentiated
immunosuppressive functions. In this context, it is notewor-
thy that PMA-triggered chemiluminescence, a parameter of
macrophageactivationonthebasisofROI-producingability,
was about twice as strongly increased in euthymic splenic
macrophages than athymic splenic macrophage due to MAC
infection. Therefore, MAC-induced splenic macrophages of
both strains of mice were functionally activated in terms of
an increase in PMA-responsiveness for a respiratory burst,
although the activation was less extensive in athymic mice
than in euthymic mice. Second, anti-TNF-α, anti-IFN-γ,a n d
anti-TGF-β antibodies (Abs) but not anti-IL-6 Ab inhibited
the MAC-induced generation of suppressor macrophages in
vivo, and the neutralizing eﬃcacy was in the order of anti-
IFN-γ Ab > anti-TNF-α Ab > anti-TGF-β Ab [88]. In addi-
tion, the treatment of normal macrophages with either TNF-
α plus IL-1α or TNF-α plus IFN-γ yielded a marked increase
in the suppressor activity, with IL-1α plus IFN-γ having less
of an eﬀect [88]. These ﬁndings indicate the important roles
of TNF-α,I F N - γ,a n dI L - 1 α in the MAC-induced generation
of suppressor macrophages. Notably, TNF-α plus IFN-γ was
the most active combination of cytokines tested, implying
that T cell- and NK cell-derived IFN-γ plays an important
role in the development of suppressor macrophages in hosts
with MAC infections in addition to monokines such as
TNF-α and IL-1α. In this context, a recent ﬁnding by
Tatano et al. is interesting [92]. They examined proﬁles of
the M. intracellulare-induced generation of immunosup-
pressive macrophages in MAC-susceptible BALB/c (bcgs)
and resistant CBA/JN (bcgr) mice. They found that MAC
infection in BALB/c mice caused the more rapid generation
of immunosuppressive macrophages than MAC infection
induced in CBA/JN mice. The suppressor macrophage pop-
ulation expressing macrophage markers, such as CD11b and
F4/80, exhibited an increased ability to generate ROIs, and
inhibited IL-2R expression by mitogenic T cells [92]. Thus,
the bcg gene may be related to the generation of immuno-
suppressive macrophages in host mice.
In the case of Mycobacterium lepraemurium infection in
mice,similartypesofmechanismsfortheproductionofsup-
pressor macrophages have also been reported [93–95]. The
progressive impairment of cell-mediated immune functions
in M. lepraemurium-infected mice has been attributed to the
emergence of suppressor cells belonging to macrophage lin-
eages.Gosselinetal.indicatedthatsuppressorprecursorcells
were generated in spleen cells of M. lepraemurium-infected
hosts harvested between 9 and 17 weeks after infection. The
suppressor precursor cells (FcγR+CD11b+Ia+IgG−asialo-
GM1− adherent cells) were matured and developed sup-
pressor activity against Con A-induced T-cell mitogene-
sis in response to stimulatory signals given by cell-to-
cell contact (presumably involving a receptor-ligand type
interaction) with nonadherent cells (FcγR+CD11b+Ia−Thy-
1−CD4−CD8−IgG−asialo-GM1− cells), which were distinct
from mature T, B, and NK cells in vitro [93]. In this
case, protein synthesis by the nonadherent regulatory cells
was needed to exert their activity to cause maturation of
the precursor suppressor macrophages [94]. The resulting
suppressor macrophages depressed the Con A-mitogenic
response of T cells through the inhibition of IL-2 production
and expression of high-aﬃnity IL-2R [95]. The expression
of the suppressor macrophage activity was at least partly
mediated by IFN-γ and prostaglandins. It should be noted
that, in the case of M. lepraemurium infection, IFN-γ is
not needed for the generation of suppressor macrophages in
vitro,althoughthiscytokineplaysacriticalroleintheinvitro
and in vivo induction of suppressor macrophages in MAC-
infectedmice.Therefore,itappearsthattheremaybevarious
mechanisms for the development of suppressor macrophage
populations during the course of mycobacterial infections,
depending on the mycobacterial species as an etiological
agent, phase of infection, bacterial dose, and so forth.
5.3. Mechanisms for the Expression of Suppressor Activity by
MAC-Induced Immunosuppressive Macrophages and Those
Induced by MTB Infection. A series of studies on immu-
nological mechanisms for the suppressor activity of immu-
nosuppressive macrophages generated by MAC infection
(MAC-induced suppressor macrophages) revealed the fol-
lowing. First, MAC-induced suppressor macrophages mark-
edlyinhibitedtheexpressionofIL-2RbyConA-stimulatedT
cells, while only moderately reducing IL-2-producing ability
of T cells [87, 89, 91]. It thus appears that the major
target of the MAC-induced suppressor macrophages is in
the T-cell activation process acquiring IL-2 responsiveness
through upregulation of IL-2R expression in response to
T cell stimulating signals. Second, when either anti-TNF-
α, anti-TGF-β, or anti-IFN-γ Ab was added to the culture
medium, suppressor activity was markedly reduced, in the
order of anti-TNF-α, anti-IFN-γ, and anti-TGF-β Abs [96].
By contrast, neither anti-IL-6 nor anti-IL-10 Ab exerted
such a blocking eﬀect. Therefore, TNF-α,I F N - γ,a n dT G F -
β seem to be related to the full display of the suppressor
function of MAC-induced suppressor macrophages. How-
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lacking in inhibitory action against Con A-stimulated T-cell
mitogenesis, when added exogenously. Hence, it is unlikely
that TNF-α and IFN-γ directly modulated the proliferative
response of T cells. On the other hand, both TNF-α and
IFN-γ potentiated the eﬀector function of the suppressor
macrophages, whereas TGF-β acted to block the suppressor
activity of MAC-induced immunosuppressive macrophages.
In this context, when splenocytes harvested from MAC-
infected mice were stimulated with Con A, membrane-
bound TNF-α molecules were strongly expressed by MAC-
induced splenic macrophages and large amounts of IFN-γ
weresecretedfromMAC-inducedsplenicTcells[96].There-
fore, both TNF-α and IFN-γ produced by the MAC-induced
suppressor macrophages themselves and MAC-sensitized T
cells, respectively, act as the major regulatory cytokines
that up-regulate the suppressor activity of MAC-induced
macrophages in an autocrine or paracrine fashion. Third,
since the suppressor activity of MAC-induced suppressor
macrophages was severely blocked by NG-monomethyl-L-
arginine (NMMA) and aminoguanidine (NOS inhibitors),
an RNI-dependent mechanism is important for the expres-
sion of the immunosuppressive function of MAC-induced
suppressor macrophages [96–98]. Indeed, this concept was
supported by the ﬁnding that NOR 4 (nitric oxide donor)-
derived RNIs actually inhibited Con A-induced T-cell mito-
genesis [98]. Fourth, it is thought that other kinds of medi-
ators, including PGE2 and free fatty acids, such as oleic acid
and arachidonic acid, participate in the suppressor functions
of the MAC-induced immunosuppressive macrophages for
the following reasons [97, 98]. The suppressive activity of the
suppressor macrophages was partly but signiﬁcantly blocked
by both indomethacin and quinacrine [98]. Moreover, both
PGE2 and oleic acid actually suppressed Con A-induced T-
cell proliferation. Phosphatidylserine (PS) was also found to
exhibit strong inhibitory activity against T-cell mitogenesis,
suggesting that it may also act as a mediator of the MAC-
induced suppressor macrophages [98].
It has been found that MAC-induced suppressor macro-
phages also exhibit inhibitory activity against LPS-induced
B-cell mitogenesis [99]. While NMMA and Carboxy-PTIO
(nitric oxide scavenger) eﬀectively blocked the macrophage
suppressor activity against Con A-induced T-cell mitogen-
esis, the suppressor action against B-cell mitogenesis was
only weakly aﬀected by these nitric oxide-reducing agents.
Notably, B-cell mitogenesis was remarkably more susceptible
to RNIs than T-cell mitogenesis. In addition, B-cell mito-
genesis was less susceptible to the inhibitory eﬀects of the
other suppressor macrophage-derived mediators, including
free fatty acids, TGF-β and PGE2, than T-cell mitogenesis.
Therefore, there are signiﬁcant diﬀerences in the modes
of suppressor action of MAC-induced suppressor macro-
phages against T-cell and B-cell mitogenesis [99]. Alter-
natively, it is also possible that MAC-induced suppressor
macrophage populations are composed of two subpopula-
tions with distinct functional properties: M1-type suppres-
sor macrophages which mainly suppress T-cell functions
in an RNI-dependent manner and M2-type suppressor
macrophages which mainly act on B cells by producing
suppressor mediators other than RNIs, presumably IL-10,
TGF-β, and so on.
Because the suppressor macrophages are generated not
only in MAC-infected mice but also MTB-infected mice, the
proﬁle of the generation and characteristics of suppressor
macrophages during the course of MTB and MAC infections
was investigated [88]. In both infections, a marked reduction
in the Con A mitogenic response of splenic T cells was seen
around 2 weeks after infection, and this was accompanied by
the generation of potent immunosuppressive macrophages
in the splenocytes of infected mice. The suppressive activity
was much stronger in MTB-infected mice than in MAC-
infected mice. In both infections, most of the suppressive
macrophages exhibited suppressor activity that depended
on the arachidonic acid cascade, particularly mediated by
prostaglandins, and the remainder showed suppressor action
independent of prostaglandins. The unique ﬁnding was
that the generation of IL-2 reactive T-cell populations in
splenocytes in response to the Con A signal was markedly
inhibited by MAC- and MTB-induced immunosuppressive
macrophages, whereas the suppressor macrophages failed to
potently reduce the IL-2-producing ability of splenic T cells
[88]. In this context, it has also been reported that the sup-
pressor macrophages induced by ﬁlarial nematode, Brugia
malayi, suppressed T-cell proliferation without causing the
reduction of cytokine (IL-4) production by the target T cells
[69]. In any case, these ﬁndings indicate a close similarity
in immunosuppressive macrophages induced by MAC and
MTB infections.
5.4. Mechanisms of Intercellular Transduction of the Sup-
pressor Signals through Cell-to-Cell Contact from Suppressor
Macrophages to Target T Cells. In the case of suppressor
macrophages generated by M. lepraemurium infections,
functional maturation of the suppressor precursor cells to
acquire their suppressor activity was found to be dependent
on cell-to-cell contact, presumably involving a receptor-
ligand type interaction, with nonadherent regulatory cells
[93]. Similarly, the inhibition of Con A-induced T-cell
proliferation by MAC-induced suppressor macrophages was
found to be dependent on cell contact of the suppressor
macrophages with target T cells [98, 100]. That is, the
expressionofthesuppressoractivityofMAC-inducedsplenic
macrophages was markedly reduced by separating target T
cells from the macrophages using a Millipore ﬁlter in a dual
chamber. In this case, the addition of mitomycin C-treated
splenocytes to MAC-induced suppressor macrophages in the
“bottom chamber,” allowing cell-to-cell contact between the
two, did not potentiate the humoral factor- (RNIs, PGE2,
etc.) mediated expression of the suppressor activity of MAC-
induced splenic macrophages through the Millipore ﬁlter.
These ﬁndings indicate the following (Figure 2): (1) Intercel-
lular transduction of suppressor signals from MAC-induced
splenic macrophages to the target T cells is mediated by cell-
to-cell contact between the two. (2) Cell contact between
MAC-induced suppressor macrophages and splenocytes did
not modulate the production of suppressor mediators such
as RNI, free fatty acids (FFAs), phosphatidylserine (PS),
PGE2,a n dT G F - β [96–98] by the macrophages themselves.12 Clinical and Developmental Immunology
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Figure 2: Mechanisms of intercellular transduction of immunosuppressive signals from MAC-induced suppressor macrophages to target T
cells.
As described above, PS exhibits strong inhibitory activity
against T-cell mitogenesis, suggesting that it acts as a
mediator of the MAC-induced suppressor macrophages [97,
98]. Notably, PS-mediated inhibitory activity against T-cell
mitogenesis was not inhibited by quinacrine (phospholipase
A2 inhibitor), thereby excluding the possibility that PS-
derived free fatty acid moieties did not mediate the T cell-
suppressing activity of PS [98]. In this context, it has been
demonstrated that human alveolar macrophages exerted
suppressor activity against PHA-induced T-cell mitogenesis
through cell-to-cell contact with target lymphocytes [59,
101]. This inhibitory activity was partly attributable to a
hydrophobic substance, which contained phosphatidylglyc-
erol. Thus, it seems that intact PS and phosphatidylglycerol
are needed for the suppressor activity. It is of interest
that PS transported to the external leaﬂet of the plasma
membrane acts as a membrane “ﬂag” on apoptotic cells,
resulting in the recognition and engulfment of these cells
by phagocytes which possess PS receptors [102]. Therefore,
the suppressor signal transmission from MAC-induced sup-
pressor macrophages to target T cells via cell-to-cell contact
seems to be partly mediated by PS molecules expressed on
the surface of the macrophages.
In addition, molecular biological studies on proﬁles
of cell contact-mediated signal transduction from MAC-
induced suppressor macrophages to the target T cells
indicated the following [100, 103]. Ogasawara et al. [100]
reported interesting ﬁndings as follows. First, the immuno-
suppressive macrophages displayed suppressor activity in
an H-2 allele-unrestricted manner, indicating that MHC
molecules are not required for cell contact. The macrophage
suppressor activity was reduced markedly by paraformalde-
hyde ﬁxation or treatment with cytochalasin B or colchicine,
indicatingthatvitalmembranefunctionsarerequiredforthe
immunosuppressive activity. Second, the suppressor activity
of MAC-induced suppressor macrophages was indepen-
dent of cell-to-cell interaction via CD40 ligand/CD40 and
macrophage-derived indoleamine 2,3-dioxygenase, which
causes rapid degradation of tryptophan in T cells. Third,
precultivation of splenocytes with MAC-induced suppressor
macrophages, allowing cell-to-cell contact, reduced Con
A- or anti-CD3 antibody-induced mitogenesis but not
PMA/calcium ionophore A23187-elicited proliferation of T
cells. In addition, cocultivation of T cells with MAC-induced
suppressor macrophages caused marked changes in proﬁles
of the tyrosine phosphorylation of 33-kDa, 34-kDa, and
35-kDa proteins and, moreover, the activation of protein
kinase C (PKC) and its translocation to the cell membrane.
It thus appears that suppressor signals of MAC-induced
macrophages, which are transmitted to the target T cells via
cell contact, principally cross-talk with the early signaling
events before the activation of PKC and/or intracellular
calcium mobilization.
Although the 33-, 34-, and 35-kDa proteins have not
yet been identiﬁed, the following can be stated. First, these
proteins are distinguished from Fyn, Lck, ZAP-70, Vav, Hs1,
Cb1, SLP-76, Grb-2, LAT, SOS, and PI3K, which are known
to play roles in the early stages of T-cell receptor (TCR)
signaling [104, 105], on the basis of their molecular weights.
Similarly, on the basis of molecular weight, the 33-kDa
and 34-kDa proteins are also distinguished from Csk, SHP-
1, gab2 and SHIP-1 that suppress TCR signaling pathways
via inhibition of Fyn and Lck [104, 105]. Second, the 35-
kDa protein may correspond to HS1-associating protein X-1
(HAX-1), which is directly associated with HS1, a substrate
of the Src family and Syk/ZAP-70 tyrosine kinases that
play important roles in the early events of TCR-mediated
signaling in T cells [106, 107]. The 35-kDa protein mayClinical and Developmental Immunology 13
also correspond to a protein which is phosphorylated by
a CD8-coupled protein-tyrosine kinase p56lck [108]. In
any case, it is noteworthy that there is cross talk between
suppressor macrophage-mediated suppressor signals, which
are transmitted to target T cells via cell-to-cell contact, and
TCR-associatedsignalingpathways,therebycausingtheinhi-
bitionoftyrosinephosphorylationofcertainproteins.Inthis
context, a separate experiment showed that the reduction of
cAMP levels in target T cells did not aﬀect the MAC-induced
suppressor macrophage-mediated suppression of Con A-
induced T-cell mitogenesis [100]. It is thus unlikely that
the suppressive signals from the suppressor macrophages
cross-talk with the activation of cAMP-dependent protein
kinase or its downstream events hindering T-cell activation
processes, such as inhibition of TCR ligation-coupled Lck
autophosphorylation and intervention in the activation of
ERK and JNK [109, 110].
Further investigations by Shimizu et al. [103] concerning
mechanisms of signal transduction from MAC-induced sup-
pressor macrophages to target T cells revealed the following.
First, it was found that a novel B7-1-like molecule (B7-
1LM) recognizable with one of three test clones of anti-B7-
1 monoclonal Abs (mAbs) was required for expression of
the macrophage suppressor activity. Neither anti-B7-2, anti-
intercellular adhesion molecule-1 (ICAM-1), nor antivascu-
lar cell adhesion molecule-1 (VCAM-1) mAb blocked the
macrophage suppressor activity. These ﬁndings suggest that
transmission of the suppressor signals from MAC-induced
suppressor macrophages to target T cells via cell contact
was dependent on B7-1LM, which shares in part the same
epitope with B7-1. This concept is further supported by
the following ﬁndings [103]. (1) The expression of B7-
1LM on MAC-induced splenic macrophages was correlated
with their suppressor activity. (2) Cell-to-cell binding of
MAC-induced suppressor macrophages with target T cells
was inhibited by the anti-B7-1 mAb (clone 16-10A1). (3)
The blocking of cytotoxic T-lymphocyte-associated protein
4 (CTLA-4) molecules on target T cells did not attenuate
the macrophage suppressor activity, indicating that CTLA-
4 does not act as a B7-1LM receptor, and that macrophage-
derived suppressor signals are transmitted to target T cells
through the interaction of B7-1LM with unknown putative
receptor molecules other than CTLA-4 on the T cells.
Separate experiments indicated that CD28 does not act as a
B7-1LM receptor either. In any case, these ﬁndings indicate
that a B7/CTLA-4-independent mechanism is needed for the
transmission of the suppressor signals from MAC-induced
suppressor macrophages to target T cells.
Second, Con A stimulation of cellular functions of MAC-
induced suppressor macrophages was needed for eﬀective
cell contact with target T cells and subsequent expression of
the suppressor activity of the macrophages [103]. Notably,
the Con A-induced increase in the suppressor activity of
MAC-induced suppressor macrophages was not inhibited
by herbimycin A, H-7, or H-88. The results obtained
with these metabolic inhibitors suggest that Con A signal-
associated expression of the suppressor activity of MAC-
induced splenic macrophages does not involve signaling
pathways which are mediated by protein tyrosine kinases
(PTKs), PKCs, or cAMP-dependent protein kinases. On
the other hand, the calcium/calmodulin-dependent protein
kinase II (CaMKII) inhibitor KN-62 partially attenuated
the suppressor activity of the macrophages, indicating that
CaMKII-mediated signaling may play important roles in the
activation of MAC-induced splenic macrophages in response
to Con A in terms of acquisition of the suppressor activity.
In this context, it is noteworthy that KN-62 has inhibitory
activity against ATP/P2X7 receptors [111]. It has been
reported that ATP-induced stimulation of P2X7 receptors
on macrophages is associated with a marked increase in
the activity of phospholipase D, causing a potentiation of
the antimycobacterial activity of the macrophages [112].
Notably, it has been reported that ATP-induced microbicidal
a c t i v i t yo fm a c r o p h a g e si sa t t e n u a t e db yK N - 6 2b u tn o t
by inhibitors of PTK, PKC, and adenylate cyclase [111].
Therefore, it is possible that ATP/P2X7 interaction on MAC-
induced splenic macrophages is needed for their suppressor
activity against target T cells.
6. Concluding Remarks
Suppressor macrophage populations having extensive
immunosuppressive activity against lymphocyte functions
are generated during the course of mycobacterial infections,
particularly in hosts with severe infections. There have been
reports of the generation of such suppressor macrophages
in cases of human or mouse infections with MTB, M. bovis
BCG, MAC, and M. lepraemurium. Suppressor macrophages
are also likely to be generated by infections of pathogenic
nontuberculous mycobacteria other than MAC, such as M.
kansasii, M. marinum, M. scrofulaceum, M. gordonae, M.
ulcerans, M. fortuitum,a n dM. abscessus. The generation of
suppressor macrophages is closely related to the subsequent
severe and persistent impairment of host T lymphocyte
functions, such as antigen/mitogen-induced proliferative
response, cytokine production, and cytotoxic capacity in a
mixed lymphocyte reaction [83, 84]. It thus appears that
suppressor macrophages participate in the abrogation of
host immune resistance to mycobacterial pathogens in the
advanced stages of infection. In particular, with respect to
the suppressor macrophage populations induced by MAC
infection, the following suggestions can be made.
First, based on macrophage polarization, macrophages
are composed of four subpopulations having functional
properties characteristic of (1) M1-type classically activated
(IFN-γ/TNF-α-induced) macrophages, (2) M2a-type alter-
natively activated (IL-4/IL-13-induced) macrophages, (3)
M2b-typetypeII(immunecomplex-andTLR/IL1-Rligand-
induced) macrophages, and (4) M2c-type deactivated (IL-
10-induced) macrophages [17, 18]. Macrophages belonging
to M2 types are known to produce large amounts of anti-
inﬂammatory/immunomodulatory cytokines, IL-10 (M2a,
M2b, M2c macrophages), and TGF-β (M2c macrophages) as
central mediators of their immunosuppressive eﬀects on T-
cell functions [17, 18]. As reported by Schreiber et al. [16],
MTB-induced excessive expression of IL-10 in macrophages
promotes the M2 (M2c) polarization program displaying
diminished antimycobacterial function of macrophages.14 Clinical and Developmental Immunology
Transgenic mice overexpressing IL-10 in a macrophage-
speciﬁc fashion were indeed susceptible to MTB infection,
displayed a speciﬁcally suppressed IL-12 in infected tissues,
and were characterized by lung macrophages with an M2
phenotype enabling MTB infection. Taken together, it is
thought most of suppressor macrophages generated due to
heavy/advanced infection by mycobacterial pathogens may
correspond to M2 macrophage populations.
It is unknown why protective cytokines, such as IFN-γ
and TNF-α, lead to the generation of immunosuppressive
macrophage populations in the case of MAC infection. As
described previously (Section 2), after MAC infection, the
ﬁrst responder M1 macrophages generated in response to
the signaling of TNF-α,I L - 1 β,a n dI F N - γ usually exhibit
an inﬂammatory phenotype and secrete proinﬂammatory/
microbicidal mediators, such as RNIs and ROIs, thereby
causing the activation of antimicrobial mechanisms charac-
teristic of M1 classically activated macrophages. However,
these radicals are toxic and highly damaging to neighboring
tissues. Therefore, M1 macrophages must be controlled
to prevent collateral extensive tissue damage by regulatory
mechanisms, including the generation of M2 alternatively
activated macrophages, which antagonize M1 macrophage
polarizationandalsoexhibitstronganti-inﬂammatoryactiv-
ity [19]. The resulting M2 macrophages are detected as sup-
pressor macrophages induced due to MAC infection in mice
(Section 5.2).
In this context, the possibility cannot be excluded
that M1 classically activated macrophages may also exhibit
suppressor activity against T cell functions, since they secrete
RNIs, which act as immunosuppressing eﬀectors against
T cell proliferation. Indeed, in the authors’ experimental
model, suppressor macrophages, which were induced by
MAC infection, exerted their suppressor activity by produc-
ing RNI molecules, the production of which is a critical phe-
notype of M1 classically activated macrophages [17–19, 97,
98]. Indeed, this is also the case for suppressor macrophages
generated in response to trypanosomal infections [66]. In
addition, the immunosuppressive activity of MAC-induced
suppressor macrophages is strongly correlated with their
ability to produce ROIs, which are exclusively produced by
M1 macrophages [17, 20, 21]. However, M2b macrophages
(type II-activated macrophages/regulatory macrophages)
characterized by low IL-12 and high IL-10 production have
a phenotype of iNOShigh, thereby having a potent activity
t op r o d u c eR N I s[ 29, 30, 113]. Therefore, it is also possi-
ble that M2b macrophages involved in the MAC-induced
suppressor macrophage populations exhibited suppressor
activity against T-cell functions instead of M1 macrophages.
It is therefore necessary to determine whether such M1
macrophages possessing suppressor activity can be truly
identiﬁed as suppressor macrophages, by performing further
studies.
Second, it can be concluded that the suppressive signals
fromMAC-inducedsuppressormacrophagesaretransmitted
to target T cells through cell contact between a novel B7-
like cell surface molecule on the macrophage and certain
receptor(s) other than CTLA-4 and CD28 on target T cells
(Figure 2)[ 103]. Moreover, it is thought that the suppressor
signals of MAC-induced macrophages are at least partly
transmitted to target T cells via cell-to-cell contact in
addition to intercellular interaction between the suppressor
macrophages and T cells using humoral suppressor media-
tors, such as RNIs, PGE2, free fatty acids (FFA), and TGF-
β. Interestingly, the suppressor signals transmitted to target
T cells by cell-to-cell contact are thought to cross talk
with tyrosine phosphorylation-mediated signal transduction
pathways in the TCR-associated signaling events in target
T cells [100, 103]. It is of interest to know the precise
roles of 33-kDa, 34-kDa and 35-kDa proteins, the tyrosine
phosphorylation proﬁles of which are signiﬁcantly aﬀected
due to the suppressor signals transmitted from MAC-
induced suppressor macrophages to target T cells via cell
contact, in the expression of inhibitory activity of the
suppressor macrophages against T-cell functions. Further
studies based on molecular biology and cell technology are
desiredtoelucidatetheprecisemechanismsofthesuppressor
macrophage-mediated downregulation of T-cell functions.
Third, with respect to variations in the properties
of suppressor macrophage populations depending on the
pathogen, the following conclusion may be possible, on
the basis of the nature of extracellular mediator molecules
in the expression of inhibitory activity against T-cell pro-
liferation. The immunosuppressive macrophages induced
by MAC exhibit their suppressor activity by producing
RNIs and prostaglandins as immunosuppressive mediators
[96–98]. This feature is common to those of suppressor
macrophages induced by a protozoa Trypanosoma brucei
rhodesiense [65, 66]. Although the suppressor activity of
Toxoplasma gondii-induced macrophages is also dependent
on RNIs, as in the case of MAC-induced suppressor
macrophages, IL-10 plays important roles as a suppressor
mediator in T. gondii-induced macrophages but not in
MAC-induced macrophages [67]. Notably, Brugia malayi-
induced suppressor macrophages exert suppressor activity
using IL-10 as a mediator [71]. Moreover, although ROIs
plays no signiﬁcant roles as a mediator of Trypanosoma
congolense-induced suppressor macrophages as in the case
of MAC-induced suppressor macrophages, the latter but
not the former macrophages use prostaglandins as a sup-
pressor mediator [64, 98]. These situations may indicate
that the common extracellular mediators of the suppressor
macrophages induced by MAC and protozoal infections
are all RNIs. In contrast, the modes of participation of
other mediator molecules, such as prostaglandins and IL-
10, in the manifestation of immunosuppressive activity
of infection-induced suppressor macrophages diverse vary
among pathogens.
Fourth,itisofinteresttoknowtherolesofMAC-induced
suppressor macrophages in the development or diminish-
mentoftheprotectiveimmunity ofhostsagainstMACinfec-
tion. In mice given large challenge doses of MAC, suppressor
macrophages were generated in the spleen of host mice
during weeks 2 to 3 after infection, followed by subsequent
reduction of the responsiveness of splenic T cells to
Con A stimulation and TCR signaling induced by anti-
CD3/anti-CD28 antibodies. This reduction was very severe
and sustainable for long periods, especially in the case ofClinical and Developmental Immunology 15
MAC-susceptible BALB/c strain mice [92]. Therefore, MAC-
induced suppressor macrophages are thought to cause long-
term downregulation of T-cell functions in host animals,
causing severe impairment of the onset of the T cell-
mediated mycobacterial antigen-speciﬁc immune response
and the establishment of prolonged reduction of protective
immunity against MAC. Therefore, control of the generation
of such suppressor macrophages may be useful for clinical
control and vaccine-based prophylaxis of MAC diseases and
presumably also TB.
Finally, during the course of persistent and progressing
TBinhumans,thegenerationofimmunosuppressivemacro-
phages is frequently encountered. Indeed, in the periph-
eral blood mononuclear cells of TB patients showing low
tuberculin responses (anergy), the generation of suppressor
macrophages populations, which markedly inhibit host T-
cell proliferative responses to antigenic stimulatory signals
with tuberculin-puriﬁed proteins, have been observed by
Ellner [83]. Although only one report has been published
on the generation of a suppressor macrophage population
in the case of human TB, it has been demonstrated that
M2polarizationofhostmacrophagesisactuallyencountered
in human TB [15, 18, 45, 51]. As described above in
detail, M2 alternatively activated macrophage populations
essentially correspond to immunosuppressive macrophages.
This may indicate that suppressor macrophages aﬀect the
proﬁles of anti-MTB immune response in TB patients,
thereby causing signiﬁcant modiﬁcation of MTB-mediated
pathogenesis. Therefore, it may be beneﬁcial for clini-
cal control of refractory mycobacteriosis to prevent the
generation of suppressor macrophages, especially M2-type
immunosuppressive macrophages, during the course of
chronic infection. Since an excessive immune deviation to
Th1 and M1 programs compensatorily causes the generation
of M2-type suppressor macrophages because of homeostasis,
it is reasonable to control Th1 and M1 activation so as not to
reach excessive levels. This strategy may be achieved by using
mildly acting anti-inﬂammatory drugs or antimycobacterial
drugs, which exhibit not only antimicrobial activity but also
mild anti-inﬂammatory and/or immunosuppressing eﬀects.
For instance, some traditional Chinese medicines having
mild anti-inﬂammatory activity may be useful. For this
purpose, plants belonging to the genus Broussonetia,w h i c h
are used in traditional medicine in Asian countries such
as China and Japan, are expected to be useful, since these
plants exert mild anti-inﬂammatory activity [114]. Among
the major constituents of the plants, papyriﬂavonol exhibit
inhibitory eﬀects on inﬂammatory secretory phospholipase
A2 and broussochalcone and kazinol suppress RNI pro-
duction [114]. In addition, macrolides are known to have
immunomodulatory eﬀects that are beneﬁcial for patients
suﬀering from chronic pulmonary inﬂammatory syndrome,
such as diﬀuse panbronchiolitis, cystic ﬁbrosis, asthma and
bronchiectasis [115]. It is expected that future systematic
studies will provide good evidence for this strategy. This
strategy may be applicable to development of new useful
vaccines against TB and MAC diseases.
Overall, this paper has described the cellular character-
istics of suppressor macrophages and, moreover, M2-type
immunosuppressive macrophages induced by mycobacte-
rial and protozoal infections. Unfortunately, essentially no
reports have described the nature of suppressor (immuno-
suppressive) macrophages induced by general microbial
infections, such as those due to common bacteria and fungi,
other than mycobacterialinfections (TB and MAC infection)
and protozoal infections, as far as we have searched using
internet document retrieval systems. Future studies on the
suppressor macrophages generated in hosts suﬀering from
infections with various types of bacterial infections will
elucidate interesting features of suppressor macrophages,
particularly the cellular mechanisms of their suppressor
activity.
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